Aptamers engineered nanocarriers for cancer therapy /

Aptamers Engineered Nanocarriers for Cancer Therapy details the selection technologies, biological characteristics, and clinical uses of aptamer-based nano agents for cancer therapeutics. The book helps facilitate speedy solutions for some of the problems pertaining to the manufacture of nano-aptame...

Full description

Bibliographic Details
Corporate Author: ScienceDirect (Online service)
Other Authors: Kesharwani, Prashant (Editor)
Format: eBook
Language:English
Published: Cambridge, MA : Woodhead Publishing, [2023]
Series:Woodhead Publishing series in biomaterials.
Subjects:
Online Access:Connect to the full text of this electronic book
Table of Contents:
  • 1. Cell-SELEX technology for aptamer selection
  • 2. Biological characteristics of aptamers
  • 3. Mechanisms of multi-drug resistance of cancer
  • 4. Relevance of aptamers as targeting ligands for anticancer therapies
  • 5. Aptamers as smart ligands for nano-carriers cancer targeting
  • 6. Aptamer-functionalized liposomes for targeted cancer therapy
  • 7. Aptamer-functionalized micelles for targeted cancer therapy
  • 8. Aptamer-functionalized nanoparticles for targeted cancer therapy
  • 9. Aptamer-functionalized PLGA nanoparticles for targeted cancer therapy
  • 10. Aptamer-functionalized silica nanoparticles for targeted cancer therapy
  • 11. Aptamer-functionalized gold nanoparticles for targeted cancer therapy
  • 12. Aptamer-functionalized dendrimers for targeted cancer therapy
  • 13. Aptamer-functionalized carbon nanotubes for targeted cancer therapy
  • 14. Aptamer-functionalized quantum dots for targeted cancer therapy
  • 15. Cancer immunotherapy via nucleic acid aptamers
  • 16. Aptamer-based imaging and diagnostics for cancer cells
  • 17. Microdevice-based aptamer sensors
  • 18. Aptamer-based microfluidics for circulating tumor cells
  • 19. Aptamer-based theranostic approaches for treatment of cancer
  • 20. Challenges of aptamers as targeting ligands for anticancer therapies
  • 21. Clinical use and future perspective of aptamers